Figure 1.

Treatment of Probio-M9 ameliorated azoxymethane/dextran sulfate sodium (AOM/DSS)-induced inflammation in a colitis-associated cancer (CAC) mouse model. (A) Treatment schedule and body weight (BW) changes for each group over the period of the experiment. Data are indicated in box-plot graphs. (B) Stool consistency score was interpreted as follows: 0, normal; 1, slightly loose stool; 2, severely loose stool; 3, diarrhea. (C) Representative images of colon morphology, total number of tumor, and estimated tumor size per mouse. n = 10. * p < 0.05; ** p < 0.01. n.s. means not significantly error.